Cytokinetic studies of oral cancer cells using bromodeoxyuridine labelling in relation to factors influencing prognosis

Fabrikant, 1969, Kinetics of cellular proliferation in normal and malignant tissue, V. Analysis of labelling indices and potential tissue doubling time in human tumor cell populations, J Surg Oncol, 1, 23, 10.1002/jso.2930010106 Steel, 1977, Cell population kinetics of human tumors, 185 Lioveras, 1994, In vitro bromodeoxyuridine labelling of malignant neoplasms—A comparative study with flow cytometry cell cycle analysis, Am J Clin Pathol, 101, 703, 10.1093/ajcp/101.6.703 Nishizaki, 1988, Cell kinetics studies of brain tumors by in vitro labelling using the anti-BrdU monoclonal antibody, J Neurosurg, 69, 371, 10.3171/jns.1988.69.3.0371 Silvestrini, 1988, Breast cancers: contribution of cell kinetics to prognosis and treatmen, 388 Wilson, 1985, Measurement of cell kinetics in human tumors in vivo using bromodeoxyuridine incorporation and flow cytometry, Cytometry, 6, 641, 10.1002/cyto.990060621 Clark, 1992, Prognostic significance of S-Phase fraction in good-risk, node negative breast cancer patients, J Clin Oncol, 10, 428, 10.1200/JCO.1992.10.3.428 Cooke, 1992, Tumor growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry, Br J Cancer, 65, 698, 10.1038/bjc.1992.147 Bourhis, 1991, Cell kinetic measurement of oropharyngeal carcinoma using in vivo incorporation of bromodeoxyuridine and flow cytometry, Bull DU Cancer, 78, 1045 Roncucci, 1992, Cell kinetics evaluation of colorectal tumours after in vivo administration of bromodeoxyuridine, Int J Cancer, 52, 856, 10.1002/ijc.2910520604 Patel, 1993, Study of the proliferation in human gastric mucosa after in vivo bromodeoxyuridine labelling, Gut, 34, 893, 10.1136/gut.34.7.893 Hemmer, 1990, In vitro bromodeoxyuridine labelling of squamous cell carcinomas of the oral cavity, Eur J Cancer, 26, 113, 10.1016/0277-5379(90)90292-2 Miltenburger, 1986, S-phase detection with a monoclonal antibody, Vol. 66, 91 Gratzner, 1982, Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: a new reagent for detection of DNA replication, Science, 218, 474, 10.1126/science.7123245 Teodori, 1990, Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (Brdu) monoclonal antibody method: comparison with DNA flow cytometry data, Int J Cancer, 45, 995, 10.1002/ijc.2910450602 Raza, 1985, Double labelling of S-phase murine cells with bromodeoxyuridine and a second DNA specific probe, Cancer Res, 45, 2283 Fujimaki, 1991, Correlation between bromodeoxyuridine labelling indices and patient prognosis in cerebral astrocytic tumors of adults, Cancer, 67, 1629, 10.1002/1097-0142(19910315)67:6<1629::AID-CNCR2820670626>3.0.CO;2-E Suibuya, 1993, Proliferative potential of brain tumours—Analysis with Ki 67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labelling and nucleolar organizer region count, Cancer, 71, 199, 10.1002/1097-0142(19930101)71:1<199::AID-CNCR2820710131>3.0.CO;2-S Bolger, 1993, Measurement of cell kinetics in cervical tumors using bromodeoxyuridine, Br J Cancer, 68, 166, 10.1038/bjc.1993.307 Yoshida, 1989, A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labelling, Cancer, 64, 2284, 10.1002/1097-0142(19891201)64:11<2284::AID-CNCR2820641118>3.0.CO;2-Y Rander, 1990, Immunohistochemical results obtained with bromodeoxyuridine (Brdu) labelled tumors of the head and neck, Dtsch Z Mund Kiefer Gesichtschir, 14, 116 Kazantseva, 1990, Complex assessment of tumor cell proliferation in various forms of lung cancer, Acta Histochem Suppl, 39, 155 Murakami, 1990, Correlation of proliferation index with submucosal invasion of hypopharyngeal cancer, Nippon Jibiinkoka Gakkai Kaiho, 93, 71, 10.3950/jibiinkoka.93.71 Sosaki, 1992, Measurement of bromodeoxyuridine labelling index, Ki-67 score and AgNOR count in breast cancer, Oncology, 49, 147, 10.1159/000227029 Hirons, 1993, Cell kinetics study of upper aero digestive tract squamous cell carcinoma using bromodeoxyuridine, Ann Otol Rhinol Laryngol, 102, 42, 10.1177/000348949310200108 Cawson, 1987, Vol. 13, 10 Christopherson, 1983, Carcinoma of the endometrium, V. An analysis of prognosticators in patients with favourable subtypes and stage I disease, Cancer, 51, 1705, 10.1002/1097-0142(19830501)51:9<1705::AID-CNCR2820510924>3.0.CO;2-C American Joint Committee on Cancer, 1992 Bedrossian, 1990, Immunocytochemistry, 403 Ferenczy, 1983, Cytodynamics of endometrial hyperplasia and neoplasia, Part II: in vitro DNA histoautoradiography, Hum Pathol, 14, 77, 10.1016/S0046-8177(83)80049-5 Mushika, 1989, Proliferative cell index in endometrial adenocarcinoma of different nuclear grades, Jpn J Can Res, 80, 223, 10.1111/j.1349-7006.1989.tb02296.x Takise, 1988, Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter, Cancer, 61, 2083, 10.1002/1097-0142(19880515)61:10<2083::AID-CNCR2820611025>3.0.CO;2-U Balzi, 1991, Labelling index in squamous cell carcinoma of the larynx, Head Neck, 13, 344, 10.1002/hed.2880130413 James, 1979, Mitotic index in carcinoma of the lung, Lancet, 2, 852, 10.1016/S0140-6736(79)92203-7 Weidner, 1993, Correlation of bromodeoxyuridine (BrdU) labelling of breast carcinoma cells with mitotic figure content and tumour grade, Am J Surg Pathol, 17, 987, 10.1097/00000478-199310000-00003